There is an urgent need for the design and development of new and safer drugs for the treatment of HIV infection, active against the currently resistant viral strains. New derivatives of the non-steroidal anti-inflammatory drug indomethacin bearing benzimidazoles, benzothiazole, purine and pyridine residues 8 -13 were synthesized with the aim of developing new non-nucleoside reverse transcriptase inhibitors (NNRTIs). Alternatively, new imine analogs 16 -20 were synthesized from condensation of indomethacinyl hydrazide 15, prepared from the ester 14, with various ketone precursors. Treatment of 15 with phenyl isothiocyanate or triethyl orthoformate afforded the phenylcarbonothioyl and the oxadiazole derivatives 21 and 22, respectively. The new compounds were assayed against HIV-1 and HIV-2 in MT-4 cells. Compounds 9 and 10 were the most active in inhibiting HIV-2 and HIV-1, respectively, with EC 50 ≥ 17.60 µg mL −1 and > 1.15 µg mL −1 (therapeutic indexes (SI) of ≥ 3 and < 1, respectively), and are leading candidates for further development.
Introduction
Non-steroidal anti-inflammatory drugs (NSAIDs) are important therapeutic agents for the treatment of pain and inflammation related to a large variety of pathologies [1] . NSAIDs inhibit the cyclooxgenase (COX) activity resulting in decreased synthesis of prostaglandin, leukotriene and thromboxane precursors. Several reports indicate that NSAIDs can prevent the development of various human tumors, including colon, breast, lung, gastric, and esophageal neoplasias [2] .
Indomethacin is a drug which belongs to the NSAID drug class, acts by inhibiting isoforms of cyclooxygenase 1 and 2, having activity to treat inflammatory rheumatoid diseases and relieve acute pain. Rogers et al. [3] reported the strategy of addressing the stimulation of the immune system which has been effective in reducing Alzheimer's disease progression in clinical trials related to the cyclooxygenase inhibitor indomethacin, which rapidly and efficiently penetrates the blood-brain barrier. However, indomethacin can 0932-0776 / 11 / 0900-0953 $ 06.00 c 2011 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com cause severe adverse gastrointestinal effects in humans and animals, particularly when administered orally [4] .
Recently, Kalgutkar et al. [5] have synthesized some indolyl esters and amides related to indomethacin as selective COX-2 inhibitors (Fig. 1) . Furthermore, Camaco-Camaco et al. [6] have reported the synthesis and in vitro cytotoxicity of various indomethacinderived n-alkyl-tin complexes, while Jones et al. [7] reported the cytotoxic activity of a new indomethacin Scheme 1. Synthesis of benzimidazoles 8 -10, imidazolo-pyridine 11, purine 12, and benzothiazole 13 derivatives from indomethacin (1) and various arene diamines (2 -6) and 2-aminobenzenethiol (7).
analog, 7-(4-chlorobenzoyl)-4,6-dimethoxy-2-methyl-3-phenylindole.
The metal complexes of indomethacin exhibited remarkably potent activity in humans [8] . While aspirin [9] , ibuprofen [10] , and indomethacin [11] are very weak free radical scavengers for in vitro systems, their copper complexes are very efficient free radical scavengers [12] . These drugs are thus expected to circumvent the toxicity of reactive oxygen species generated in the activated microglia. Yi and coworkers [13] reported that the copper complex exhibited higher antibacterial activity than the parent drug whose IC 50 value was 1.5 and 2.3 times lower than that of indomethacin to S. aureus and E. coli, respectively. It was indicated that when the copper ion is coupled with indomethacin, the drug is more potent as a bacteriostatic.
On the other hand, benzimidazoles were reported to be potent biological molecules as anti-ulcer, antihypertensive, antiviral, antifungal, anticancer, and antihistaminic agents [14] . Some benzimidazoles have been reported as HIV-1 reverse transcriptase inhibitors, and/or potent DNA gyrase inhibitors, for example thiazolo [3,4-a] benzimidazoles (TBZs) and their analogs [15 -17] and 1-(2,6-difluorophenyl)-thiazolo-[3,4-a]benzimidazole (NSC625487), since they inhibited the replication of various strains of HIV-1 including a zidovudine-resistant strain (G910-6) [18] . Monforte and coworkers [19] have reported the synthesis of new thiazolo [3,4-a] benzimidazoles and 2-aryl-1-benzylbenzimidazoles as HIV-1 RT inhibitors.
In continuation of our attempts in searching for new anti-HIV agents [20 -28] and on the basis of the above mentioned promising biological results, we considered benzimidazoles and their analogs particularly interesting to optimize the synthetic approaches to our antiviral agents. In this study, the anti-inflammatory drug indomethacin [29] has been selected as a main backbone for the synthesis of new benzimidazole and benzothiazole derivatives and their analogs, using the microwave irradiation method.
Results and Discussion

Synthesis
Treatment of indomethacin 1 with the appropriate 1,2-arenediamines 2 -6 or 2-amino-thiophenol (7) in the presence of p-toluenesulfonic acid (pTsOH) and Al 2 O 3 under MW irradiation (20 -30 min, 100 -150 W) afforded the benzimidazole-bearing indomethacin 8 and the related analogs 9 -13, isolated by conventional work-up, in 55 -71 % yield (Scheme 1).
The structures of 8 -13 were assigned on the basis of their 1 H, 13 C NMR and mass spectra. They showed similar NMR patterns of aliphatic and aromatic H atoms. Compounds 8 -13 showed two doublets at higher fields (δ = 7.72 -7.65 and 7.51 -7.43 ppm), attributed to 2-H arom-Cl , 6-H arom-Cl and 3-H arom-Cl , 5-H arom-Cl (J = 6.7 -7.0 Hz), respectively. The doublet at δ = 7.66 ppm was assigned to 4-H benzimidazole and 7-H benzimidazole (J = 8. and H-7 of the indole moiety appeared as doublets at δ = 6.95 -6.82 and 6.76 -6.59 ppm (J ∼ 9.0 Hz), while H-7 gave a doublet of doublets in the region δ = 7.02 -6.84 ppm (J ∼ 9.0 and ∼ 2.5 Hz). The singlets at δ = 3.81 -3.70 ppm were assigned to OMe groups, while the singlets at δ = 3.75 -3.64 ppm were attributed to methyl groups at C-2. H-6 of the pyridine residue of 11 appeared as a doublet of doublets at δ = 6.97 ppm (J = 8.8, 2.6 Hz). H-4 and H-5 of the purine moiety of 12 gave doublets at δ = 9.05 and 8.90 ppm (J = 2.2 Hz), respectively. The 13 C NMR spectra of 9 -12 were recorded (Experimental Section), and compound 13 was selected for the 13 C NMR analysis. The spectrum showed higher field signals at δ = 168.3 and 166.2 ppm which were assigned to C=O and C-2 of benzothiazole, respectively. The resonances at δ = 156.1 and 154.1 ppm were attributed to C-6 of the indole and to C-3a of the benzothiazole moieties. C-7a and C-2 of the indole appeared at δ = 136.9 and 133.8 ppm, respectively. The signals at δ = 125.6 and 121.9 ppm were assigned to C-5 and C-6 of the benzothiazole, while the signal at δ = 121.9 ppm was assigned to C-4 and C-7 of the same ring. The resonances at δ = 118.9, 118.3, 111.7, and 101.3 ppm were attributed to C-4, C-3a, C-3, C-5, and C-7 of the indole, respectively. The signals at δ = 55.8, 23.5, and 13.4 ppm were assigned to methoxy, methylene and methyl groups. The purine derivative 12 was selected for further spectroscopic analysis. From the gradient-selected HMBC spectrum [30] CH-2 at δ H = 3.68 ppm showed two heteronuclear 2 J C,H correlations: one with C-3 of the indole ring at δ C = 136.1 ppm and the other with C-2 of the purine ring at δ C = 148.9 ppm.
Next, other models of indomethacin derivatives bearing imine derivatives via an acetohydrazide linkage were prepared, aiming to evaluate their anti-HIV activity. Esterfication of 1 with acidic EtOH afforded the ester 14 (82 %) [31] , which was converted into the hydrazide 15 (64 %) [32] on treatment with hydrated hydrazine. Treatment of 15 with various ketones gave the imine derivatives 16 -20 in 82, 85, 79, 78, and 85 % yield, respectively (Scheme 2).
The assignment of protons and carbons of the indomethacin backbone was deduced in comparison to compounds 8 -12. The 1 H NMR spectrum of 14 showed a quartet at δ = 3.78 ppm (J = 7.1 Hz) and a triplet at δ = 1.19 ppm, assigned to the ethyl protons of the ester group. The signals had disappeared in the spectrum of 15 and instead, three signals at δ = 10.38, 9.86, and 9.06 ppm were seen, attributed to NH groups. Compounds 16 -20 showed singlets at δ = 3.68, 3.36, 3.37, 3.47, and 3.44 ppm, assigned to the methylene protons. In the 13 C NMR spectra of 14 and 15, the C=O carbon atoms of the ester and carbohydrazide groups resonated at δ = 170.9 and 170.7 ppm, respectively, while the amide carbon atom resonated at δ = 168.3 ppm. Compounds 16 -20 showed three resonances at δ = 170.0 -174.0, 167.9 -164.8 and 155.9 -152.9 ppm, attributed to the NHNC=O, C amide =O and C=N carbon atoms, respectively.
Further, treatment of 15 with phenyl isothiocyanate or triethyl orthoformate in boiling EtOH afforded the phenylcarbonothioyl-carbohydrazide 21 and the 1,2,4- oxadiazole analogs 22 in 78, and 62 % yield, respectively (Scheme 3). The structures of 21 and 22 were confirmed by their 1 H and 13 C NMR spectra. The 1 H NMR spectrum of 21 showed two doublets at δ = 10.02 and 9.60 ppm (J = 4.8 Hz), attributed to NH groups, which disappeared on D 2 O exchange. In the 13 C NMR spectrum of 21, the signal at lower field (δ = 187.3 ppm) was assigned to C=S, while the resonances at δ = 171.7 and 165.0 ppm were assigned to NHNC=O and C=O (amide) groups, respectively. In the 1 H NMR spectrum of 22, 5-H of the oxadiazole moiety appeared as a singlet at δ = 9.34 ppm, while its 13 C NMR spectrum showed a signal at δ = 153.0 ppm, assigned to C-5 of the oxadiazole ring. The proton and carbon signals of the indole backbone of 21 and 22 were deduced from a comparison with those of 8 -12.
In-vitro anti-HIV assay
Compounds 8 -21 were tested for their in vitro anti-HIV-1 (strain IIIB) and HIV-2 (strain ROD) activity in human T-lymphocyte (MT-4) cells based on the MTT assay [33] . The results are summarized in Table 1 , in which the data for Nevirapine (BOE/BIRG587) [34] and azidothymidine (DDN/AZT) [35] were included for comparison. Compound-induced cytotoxicity was also measured in MT-4 cells parallel with the antiviral activity.
Compounds 9 and 10 were found to be the only compounds in the series inhibiting HIV-2 and HIV-1 replication in a cell culture, respectively, which showed EC 50 values of ≥ 17.60 µg mL −1 and > 1.15 µg mL −1 with CC 50 values of > 54.08 µg mL −1 and > 1.15 µg mL −1 , respectively, resulting in a selectivity index of ≥ 3 and < 1, respectively.
Based on the chemical structure of compounds 9 and 10, these molecules can be proposed to act as nonnucleoside reverse transcriptase inhibitors (NNRTIs). However, the activity spectrum that is limited to HIV-2 (in case of compound 9) is completely in contrast with what was observed with NNRTIs.
In conclusion, the above data suggest that substitution of the aromatic ring of the benzimidazole back-bone by a nitro group would engender the inhibitory activity on HIV-2 replication that is most exceptional, while the substitution with a halogen atom (like chlorine) would enhance the activity of HIV-1.
Experimental Section
General
Melting points are uncorrected and were measured on a Büchi melting point apparatus B-545 (Büchi Labortechnik AG, Switzerland). NMR data were obtained on 400 and 600 MHz ( 1 H) and 150.91 MHz ( 13 C) spectrometers (Avance III, Bruker, Germany) with TMS as internal standard and on the δ scale in ppm. Heteronuclear assignments were verified by 1 H-13 C COSY, or HMQC experiments. Microanalytical data were obtained with a Vario, Elemental analyzer (Shimadzu, Japan). Mass spectra were recorded on EI (70 eV) and FAB MAT 8200 spectrometers (Finnigan MAT, USA). Microwave-assisted reactions were carried out in a CEM Focused Microwave Synthesis System (100 -150 W). Silica gel (0.040 -0.063 mm) used for column chromatography and analytical silica gel TLC plates 60 F254 were purchased from Merck.
General procedure for the preparation of the indomethacinyl-benzimidazole, -pyridine, -pyrimidine, and -benzothiazole derivatives 6 -13
A mixture of indomethacin (1) (537 mg, 1.50 mmol) 1,2-arenediamine (1.0 mmol), p-toluenesulfonic acid (p-TsOH) (10 mg) and Al 2 O 3 (20 mg) was thoroughly ground with a pestle in a mortar at r. t. in an open atmosphere, then irradiated in MWI. After the reaction was completed, the mixture was allowed to cool to r. t. and then partitioned between CHCl 3 (3 × 15 mL) and a dil. solution of NaHCO 3 (15 mL). The combined organic extracts were dried (Na 2 SO 4 ), filtered and evaporated to dryness. The crude product was purified on a column of SiO 2 (5 g) (eluents: hexane-EtOAc = 3 : 2 or, in gradient, MeOH (0 -10 %) and CHCl 3 ) to give the desired product.
(3-((Benzimidazol-2-yl)methyl)-6-methoxy-2-methyl-1H-indol-1-yl)(4-chlorophenyl)methanone (8)
From o-phenylenediamine (2) (108 mg). Yield: 398 mg (62 %); oil. (4-Chlorophenyl) (6- methoxy-2-methyl-3-((4-nitrophenyl-1H-benzoimidazol-2-yl)methyl)-1H-indol-1-yl) methanone (9) From 3-nitrobenzene-1,2-diamine (3) (153 mg). Yield: 488 mg (65 %); oil. 
(3-(Benzothiazol-2-ylmethyl)-6-methoxy-2-methyl-1H-indol-1-yl)(4-chlorophenyl)methanone (13)
From 2-aminobenzenethiol (7) (125 mg). Yield: 368 mg (55 %); oil. 
General procedure for the preparation of the imine derivatives of indomethacin 16 -20
A solution of 15 (371 mg, 1.0 mmol) in EtOH (15 mL) containing an appropriate ketone (1.1 mmol) was heated under reflux for 3 h. After cooling, the solution was evaporated to dryness, and the residue was partitioned between CHCl 3 (2 × 20 mL) and water (20 mL). The combined organic layers were dried (Na 2 SO 4 ) and filtered, and the filtrate was evaporated to dryness. The residue was purified by SiO 2 column chromatography using a gradient of MeOH (0 -10 %) in CHCl 3 as eluent to provide the desired product.
